MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Clinical trials for MULTIPLE SCLEROSIS, RELAPSING-REMITTING explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS, RELAPSING-REMITTING trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS, RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common allergy pill help heal MS nerve damage?
Disease control CompletedThis study tested whether clemastine fumarate, a drug originally used for allergies, can help repair the protective coating around nerves in people with relapsing-remitting multiple sclerosis (MS). Fifty adults with MS took either clemastine or a placebo for up to 3 months while …
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Blood filtering therapy shows promise for MS in small trial
Disease control CompletedThis study tested a treatment called extracorporeal photopheresis (ECP) in 15 people with multiple sclerosis (MS). ECP involves taking blood, treating it with light and a drug, then returning it to the body. The goal was to see if it is safe and might help improve walking, hand f…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: PHASE1, PHASE2 • Sponsor: Abu Dhabi Stem Cells Center • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
Real-World ozanimod study tracks RRMS patients over 3 years
Knowledge-focused CompletedThis study followed 450 people with relapsing-remitting multiple sclerosis (RRMS) who were already prescribed ozanimod (Zeposia) by their doctors. Researchers collected data over three years to see how long patients stayed on the medication, how it affected their quality of life,…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC
-
New MRI study aims to solve the mystery of MS disability
Knowledge-focused CompletedThis study looked at 94 adults with relapsing-remitting multiple sclerosis to understand why standard MRI scans often don't match a person's walking ability. Researchers used advanced MRI to measure damage in brain and spinal cord pathways that control movement and sensation. The…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: NA • Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC
-
MS Patients' switch to ozanimod under the microscope
Knowledge-focused CompletedThis study observed 104 adults with relapsing-remitting multiple sclerosis (RRMS) who had recently switched their disease-modifying therapy to ozanimod. Researchers tracked the reasons for switching—such as lack of effectiveness, side effects, or patient preference—and how the sw…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC